Interní Med. 2002; 4(10): 478-485

Funkční nemoci zažívacího traktu

MUDr. Jiří Dolina, prof. MUDr. Aleš Hep CSc, MUDr. Radek Kroupa, MUDr. Zuzana Plottová, MUDr. Marie Přecechtělová
III. interní klinika gastroenterologická, FN Brno-Bohunice

Keywords: functional gastrointestinal disorders, functional dyspepsia, irritable bowel syndrome.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dolina J, Hep A, Kroupa R, Plottová Z, Přecechtělová M. Funkční nemoci zažívacího traktu. Interní Med. 2002;4(10):478-485.

Funkční nemoci gastrointestinálního traktu (GIT) jsou značně heterogenní skupinou. Svojí ubikvitárností a značným dopadem na kvalitu života pacientů začínají ovlivňovat i socioekonomický stav národů. Aktivní přístup k funkčním onemocněním zažívacího traktu vyžaduje nové diagnostické postupy a terapeutické přístupy. Objektivizace subjektivních obtíží u funkčních poruch je zřejmě nejobtížnějším úsekem, na kterém závisí škála klasifikace a terapeutické možnosti.

Functional gastrointestinal disorders

Functional gastrointestinal disorders represent a very heterogeneous group. Being ubiquitous and having a significant impact on quality of life of patients, they have started to show an influence on social and economic conditions of nations. An active approach towards functional gastrointestinal disorders requires new diagnostic procedures and therapeutical management. The classification and therapeutical modalities of functional gastrointestinal disorders are derived from the objectification of subjective complaints, what represents the most perplexing part in diagnosis.

Download citation

References

  1. Bortolotti M, Barbara L. The Relationship between Symptoms and Gastric Dysfunction in Functional Dyspepsia. Motility 1995; 31: 7-13.
  2. Camilleri M. Dyspepsia, Irritable Bowel Syndrome and Constipation: review and What´sNew. Reviews in Gastroenterological Disorders 2001; 1: 2-17. Go to PubMed...
  3. Corinaldesi R, Stanghelini V, Raiti C. Effect of chronic administration of cisparide on gastric empyting of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987; 28: 300-305. Go to original source... Go to PubMed...
  4. Drossman DA. The Functional gastrointestinal disorders and the Rome II process. In: Drossman DA, with Editors: Rome II-The Functional Gastrointestinal Disorders-IInd. edition. Allen Press Inc Lawrence KS USA 2000; 1-30. Go to original source...
  5. Hyrdel R. Poruchy motility žalúdka. In: Bátovský M, Ďuriš I, Hildebrand T, Hyrdel R, Vavrečka A. Poruchy Gastrointestinálnej Motility a Prokinetiká. Janssen-Cilag Bratislava 1999: 39-77.
  6. Jian R, Ducrot F, Ruskone A, Chaussade S, Rambaud JC. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind, placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 657-664. Go to original source... Go to PubMed...
  7. Jirásek V. Funkční kolopatie - abstrakt. Funkční onemocnění trávicího traktu 1998; 3-4.
  8. Kellow JE, Delvaux M, Azpiroz F, et al. Principles of applied neurogastroenterology: physiology / motility-sensation. In: Drossman DA with Editors: Rome II-The Functional Gastrointestinal Disorders-IInd. edition. Allen Press Inc Lawrence KS USA 2000: 91-156.
  9. Mařatka Z. Funkční trávicí poruchy. In: Mařatka Z a spolupracovníci: Gastroenterologie. KarolinumPraha 1999: 407-433.
  10. Mařatka Z. Dyspepsie. Normed Verlag Bad Homburg 1992.
  11. Prášek J, Hep A. Radionuklidová diagnostika funkčních poruch v gastroenterologii. Medicína 1996; 3: 12.
  12. Prášek J, Hep A, Dítě P. Vyšetření evakuační schopnosti žaludku. Sborník 33 Mezinárodních Dnů nukleární medicíny v Hradci Králové 1996; 19s.
  13. Rao SSC, Schulze-Delrieu K. The stomach, pylorus and duodenum. In: Kumar D, Wingate D. Gastrointestinal Motility- IInd. edition. Churchill Communications Europe Limited 1993: 373-392.
  14. Stanghelini V, Jadallah K, Corinaldesi R. A Review of Gastric Emptying Measurement Techniques. Motility 1994; 26: 11-14.
  15. Stanghelini V, Tosetti C, Corinaldesi R. The Relationship Between Dyspeptic Symptoms and Gastric Motor Abnormalities. Motility 1997; 36: 6-8.
  16. Talley NJ, Stanghellini V, et al. Functional gastroduodenal disorders. In: Drossman DA with Editors: Rome II-The Functional Gastrointestinal Disorders-IInd. edition. Allen Press Inc Lawrence KS USA 2000: 299-351.
  17. Thomforde GM, Brown ML, Malagelada JR. Practical solid and liquid phase markers for studying gastric emptying in man. J Nucl Med Tech 1995; 13: 11-14.
  18. Thompson DG. Clinical pharmacology. In: Phillips SF, Wingate DL. Functional Disorders of the Gut Churchill-Livingstone London 1998: 43-52.
  19. Thompson WG. Epidemiology. In: Phillips SF, Wingate DL. Functional Disorders of the Gut Churchill-Livingstone London 1998: 53-70.
  20. Tonini M, DePonti F, DiNucci A, Crema F. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 1999; 13: 1585-1591. Go to original source... Go to PubMed...
  21. Tytgat GN. Patients with dyspepsia: a heterogeneous population. In: Heading RC, Wood JD. Gastrointestinal Dysmotility-Focus on Cisapride. Raven Health Care Communications NY 1992: 201-210.
  22. Wingate DL, Phillips SF. Functional anatomy and physiology. In: Phillips SF, Wingate DL. Functional Disorders of the Gut. Churchill-Livingstone, London, 1998: 3-18.
  23. Wood JD, Alpers DH. Fundamentals of neruogastroenterology: basic science. In: Drossman DA with Editors: Rome II-The Functional Gastrointestinal Disorders-IInd. edition. Allen Press Inc Lawrence KS USA 2000: 31-90.
  24. Zbořil V, Prokopová L, Geislerová V, Pokorný A, Dítě P, Mihula V. Vliv preparátu Hylak kapky na symptomatologii osob s dráždivým tračníkem. Vnitřní lékařství 1992; 8: 764-768.
  25. Zbořil V, Prokopová L, Krejčiřík P. Distální kolitida. Monografie firmy Medimport 2001: 30.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.